Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical TrialLeticia Rosario Cruz, María Margarita López Vázquez, Ariadna García et al.|ACS Pharmacology & Translational Science|2020Cited by 45
CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell ModelGeorge Perez, Silvio E. Perea|Biomedicines|2022Cited by 11
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical TrialLeticia Rosario Cruz, Idania Baladrón, Aliusha Rittoles et al.|medRxiv|2020Cited by 5
A modified variant of human Interleukin-15 as a novel antigen for active immunotherapy in rheumatoid arthritisYunier Rodríguez, Gerardo Guillén, Alicia Santos et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2018Cited by 0